Here's the licensing agreement between PYC and Phoremost dated 07/04/15. If I recall, PYC's equity stake is less than the original 7.5%. Is it about 4% now? Can someone please clarify?
https://hotcopper.com.au/threads/ann-phylogica-licenses-peptides-to-uk-company.2491070/?post_id=15041633
Tony
Ann: March 2019 Quarterly Operational Update and App4C, page-49
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |